Medicine recalls
|
| |
| Canada: Recall: JAMP-Risperidone 0.25mg: Out of specification (Stability) |
| |
Health Canada announces that JAMP Pharma Corporation is recalling 2 lots of JAMP-Risperidone 0.25mg Tablet (lot number: ENN063001, ENN062001) from retailers because the impurities are out of specification during stability in the affected lots.
The product is indicated for the acute treatment and maintenance treatment of schizophrenia and related psychotic disorders; the short-term symptomatic management of aggression or psychotic symptoms in patients with severe dementia of the Alzheimer type unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others; and monotherapy for the acute management of manic episodes associated with Bipolar I disorder.
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/jamp-risperidone-025mg-out-specification-stability
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Thursday, Nov 20, 2025
Issued at HKT 15:15
|
| |
